Active, not recruitingPhase 2NCT04283513

Treatment of Hemorrhagic Fever With Ribavirin

Studying Hemorrhagic fever-renal syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: U.S. Army Medical Research and Development Command
Intervention: Virazole(drug)
Enrollment: 50 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2022 – 2027

Study locations (1)

Landstuhl Regional Medical Center, Landstuhl, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04283513 on ClinicalTrials.gov

← Back to all trials